The Achondroplasia Treatment Market is estimated to be valued at US$ 127.8 million in 2023 and is expected to exhibit a CAGR of 36.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Achondroplasia is the most common form of disproportionate short stature in humans caused by mutations in the fibroblast growth factor...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian